drugset / Trial / NCT00002492

Combination Chemotherapy in Treating Patients With Soft Tissue Sarcoma

NCT00002492 ↗

Phase 2 Completed University of Miami
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining cisplatin and doxorubicin in treating patients who have soft tissue sarcoma.

Timeline

Start
1991-11
Primary completion
2000-02
Completion
2000-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified — Other
Subject Doxorubicin Other / unclassified — Intravenous

Indications